ECHA management board reviews strategy on substances in nanoforms
The Management Board of the European Chemicals Agency (ECHA) discussed ECHA’s strategy on substances in nanoforms at a meeting held on 14th-15th of December 2017.
A key message from the strategy states:
The possibility for using dossier and substance evaluation under the current legal text of REACH [Registration, Evaluation, Authorisation and Restriction of Chemicals] to verify safe use of nanomaterials on the EU market has become increasingly challenging and resource intensive, following recent rulings of the Board of Appeal. The lack of information on hazardous properties of nanomaterials hampers not only the identification of specific concerns but also the assessment of whether additional risk management measures are needed. The revision of REACH Annexes is therefore even more urgent than before. These developments, however, do not eliminate the responsibility of industry in ensuring the safe use of substances, in whatever form.
In March 2017, the Board of Appeal annulled a contested decision that would have required the lead registrant to provide detailed substance identity information on the crystal phases, nanoforms, and surface treatment of nanoforms covered by its registration of titanium dioxide. On June 30, 2017, the Board of Appeal published two decisions related to nanomaterials, largely upholding the appeals and annulling most of the requests for information.
The preliminary conclusions for the meeting state that the Management Board welcomed ECHA’s progress and invited the EC to conclude, as a matter of urgency, the revision of the annexes to REACH on the information requirements of nanomaterials.
Source: ECHA via Bergeson & Campbell, P.C.